News Focus
News Focus
icon url

Beck808

08/30/13 9:10 AM

#31057 RE: BeenLiedTo #31055

Time to get some pitchforks and torches
icon url

Beck808

08/30/13 9:33 AM

#31060 RE: BeenLiedTo #31055

Howard has taken the only assets of the company and caused the value of his "returned" shares to be ZERO

Sounds like usurpation of corporate opportunity and breach of fiduciary duty / breach of duty of loyalty

Corporate opportunity

Duty of loyalty

Time for class action...
icon url

EarnestDD

09/04/13 10:22 AM

#31082 RE: BeenLiedTo #31055

Howard's Resignation. So Long Investors.
Full Statement: ROCKY MOUNT, N.C., Aug. 29, 2013 (GLOBE NEWSWIRE) -- The following statement is from Howard Phykitt, President/CEO of PharmStar Pharmaceuticals, Inc. (Pink Sheets:PHAR):

August 22, 2013

Board of Directors PharmStar Pharmaceuticals, Inc.

Re: Resignation

To Whom It May Concern:

I hereby resign from the position of President, Chief Executive Officer, and Director of PharmStar Pharmaceuticals, Inc. effective immediately.

Upon resignation I will retire 405,000,000 shares of PharmStar Pharmaceuticals, Inc. common stock back to treasury. As compensation for returning the stock, the board of directors has unanimously agreed to release all intellectual property rights, patents and trademarks for soluble aspirin back to Howard Phykitt personally.

Sincerely,

Howard Phykitt

CONTACT: PharmStar Pharmaceuticals, Inc.
OTC Capital Partners
561-350-8523
www.otccapitalpartners.com